Faculty Mentor

Nicholas Burgis

Document Type

Poster

Publication Date

2020

Department

Chemistry and Biochemistry

Abstract

SARS-CoV-2 is the virus responsible for the current pandemic. SARS-CoV-2 is a betacoronavirus with a genome that is 79.5% identical to SARS-CoV. The virus enters T lymphocytes using its spike protein with the human angiotension-converting enzyme 2 as its receptor. SARS-CoV-2 was found to have a unique peptide sequence that could contribute to the proteolytic cleavage of the spike protein, therefore potentially impacting host range and transmissibility. COVID-19 is diagnosed through a nasal swab SARS-CoV-2 RT-PCR assay and the most common symptoms appear to be fever, cough, and fatigue. The median amount of time an individual will be contagious with the virus is 20 days. Many possible treatment methods have been explored including a SARS-CoV-2 specific antibody that could be potentially therapeutic against the virus, natural remedies, potential oligo-based therapies, and ACE inhibitors. There are also IgM-IgG tests being developed that detect the antibodies against SARS-CoV-2 virus in the blood that could help determine transmission of the virus in the population.

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Share

COinS